HRP20090090T3 - Novel polysubstituted 1,1-pyridinylaminocyclopropanamine derivatives, processes for their preparation and pharmaceutical composition containing them - Google Patents

Novel polysubstituted 1,1-pyridinylaminocyclopropanamine derivatives, processes for their preparation and pharmaceutical composition containing them

Info

Publication number
HRP20090090T3
HRP20090090T3 HR20090090T HRP20090090T HRP20090090T3 HR P20090090 T3 HRP20090090 T3 HR P20090090T3 HR 20090090 T HR20090090 T HR 20090090T HR P20090090 T HRP20090090 T HR P20090090T HR P20090090 T3 HRP20090090 T3 HR P20090090T3
Authority
HR
Croatia
Prior art keywords
straight
branched
branched alkyl
hydrogen atom
group
Prior art date
Application number
HR20090090T
Other languages
English (en)
Croatian (hr)
Inventor
Goldstein Solo
Guillonneau Claude
Charton Yves
Lockhart Brian
Lestage Pierre
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of HRP20090090T3 publication Critical patent/HRP20090090T3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HR20090090T 2005-07-28 2009-02-13 Novel polysubstituted 1,1-pyridinylaminocyclopropanamine derivatives, processes for their preparation and pharmaceutical composition containing them HRP20090090T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0508032A FR2889188B1 (fr) 2005-07-28 2005-07-28 Nouveaux composes 1,1-pyridinylaminocyclopropanamines polysubstitues, leur procede de preparation et les compositions phamaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
HRP20090090T3 true HRP20090090T3 (en) 2009-03-31

Family

ID=36169157

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20090090T HRP20090090T3 (en) 2005-07-28 2009-02-13 Novel polysubstituted 1,1-pyridinylaminocyclopropanamine derivatives, processes for their preparation and pharmaceutical composition containing them

Country Status (31)

Country Link
US (2) US7388022B2 (de)
EP (1) EP1757586B1 (de)
JP (1) JP2007031439A (de)
KR (1) KR100824831B1 (de)
CN (1) CN100448848C (de)
AR (1) AR055589A1 (de)
AT (1) ATE416166T1 (de)
AU (1) AU2006203237A1 (de)
BR (1) BRPI0603027A (de)
CA (1) CA2552831A1 (de)
CR (1) CR9679A (de)
DE (1) DE602006003956D1 (de)
DK (1) DK1757586T3 (de)
EA (1) EA011124B1 (de)
EC (1) ECSP088127A (de)
ES (1) ES2318700T3 (de)
FR (1) FR2889188B1 (de)
GE (1) GEP20084506B (de)
GT (1) GT200800005A (de)
HR (1) HRP20090090T3 (de)
MA (1) MA28425B1 (de)
MX (1) MXPA06008541A (de)
NO (1) NO20063462L (de)
NZ (1) NZ548746A (de)
PL (1) PL1757586T3 (de)
PT (1) PT1757586E (de)
SG (1) SG129412A1 (de)
SI (1) SI1757586T1 (de)
TN (1) TNSN08023A1 (de)
WO (1) WO2007012761A1 (de)
ZA (1) ZA200606276B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2896800B1 (fr) * 2006-01-30 2008-04-11 Servier Lab Nouveaux composes pyridinylaminoalkylene-et pyridinyloxyalkylene-cyclopropanamines polysubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US10288289B2 (en) * 2014-12-12 2019-05-14 United Technologies Corporation Gas turbine engine diffuser-combustor assembly inner casing

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2095350C1 (ru) * 1993-10-13 1997-11-10 Центр по химии лекарственных средств (ЦХЛС-ВНИХФИ) 3-(n,n-диметилкарбамоилокси)-2-этил-6-метилпиридина сукцинат, обладающий антигипоксической активностью
TW544448B (en) * 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
ATE491689T1 (de) * 1997-10-27 2011-01-15 Neurosearch As Heteroaryl diazacycloalkane als cholinergische ligande für nikotin-acetylcholin-rezeptoren
JP2003501416A (ja) * 1999-06-07 2003-01-14 ターガセプト，インコーポレイテッド 医薬組成物およびその使用法
JP2001261652A (ja) * 2000-03-21 2001-09-26 Suntory Ltd 二置換イミノヘテロサイクリック化合物
US6448276B1 (en) * 2000-05-17 2002-09-10 Inspire Pharmaceuticals, Inc. Method for treating vaginal dryness with nicotinic acetylcholine receptor agonists
FR2810664B1 (fr) * 2000-06-27 2004-12-24 Adir Nouveaux composes cyclopropaniques 1,1 et 1,2-dissubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
DE602006003956D1 (en) 2009-01-15
AR055589A1 (es) 2007-08-29
ECSP088127A (es) 2008-02-20
US20080146621A1 (en) 2008-06-19
EP1757586A1 (de) 2007-02-28
MXPA06008541A (es) 2007-01-29
FR2889188A1 (fr) 2007-02-02
KR20070015012A (ko) 2007-02-01
KR100824831B1 (ko) 2008-04-23
ATE416166T1 (de) 2008-12-15
NO20063462L (no) 2007-01-29
WO2007012761A8 (fr) 2007-12-21
ZA200606276B (en) 2007-12-27
AU2006203237A1 (en) 2007-02-15
SG129412A1 (en) 2007-02-26
BRPI0603027A (pt) 2007-03-13
CN1903844A (zh) 2007-01-31
HK1098146A1 (zh) 2007-07-13
EP1757586B1 (de) 2008-12-03
CN100448848C (zh) 2009-01-07
US20070027192A1 (en) 2007-02-01
FR2889188B1 (fr) 2007-09-07
CR9679A (es) 2008-02-20
PT1757586E (pt) 2009-02-17
EA200601247A1 (ru) 2007-04-27
CA2552831A1 (fr) 2007-01-28
TNSN08023A1 (en) 2009-07-14
ES2318700T3 (es) 2009-05-01
JP2007031439A (ja) 2007-02-08
WO2007012761A1 (fr) 2007-02-01
GT200800005A (es) 2008-09-24
DK1757586T3 (da) 2009-03-09
US7388022B2 (en) 2008-06-17
MA28425B1 (fr) 2007-02-01
NZ548746A (en) 2007-06-29
GEP20084506B (en) 2008-10-10
PL1757586T3 (pl) 2009-04-30
SI1757586T1 (sl) 2009-04-30
EA011124B1 (ru) 2008-12-30

Similar Documents

Publication Publication Date Title
ES2512491T3 (es) Derivados de la piridina pirazolo como inhibidores de la NADPH oxidasa
ES2190396T3 (es) Nuevos compuestos amino-triazoles, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
EA200970311A1 (ru) ПРОИЗВОДНЫЕ 2-АРИЛ-6-ФЕНИЛИМИДАЗО[1,2-α]ПИРИДИНОВ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В ТЕРАПИИ
AR088218A1 (es) Compuestos heterociclicos utiles como inhibidores de pi3k
WO2007016392A3 (en) Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
AR064730A1 (es) Derivados de 2,4-dianilinopirimidinas, su preparacion, composiciones farmaceuticas y usos como inhibidores de ikk
RU2003122190A (ru) Производные тетрагидропиридина, их получение и применение в качестве ингибиторов клеточной пролиферации
CO5700824A2 (es) Nuevos compuestos heterociclicos utiles para el tratamiento de desordenes inflamatorios y alergicos: proceso para su preparacion y composiciones farmaceuticas que los contienen
TW200724136A (en) Pharmaceutical compositions comprising PPAR modulator
NO331165B1 (no) Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme for fremstilling av medikamenter
HRP20080100T3 (en) Hydroisoindoline tachykinin receptor antagonists
TW200611687A (en) Pharmaceutical compositions used for immunosuppressant
UY29312A1 (es) Piperazin-1-carboxamidas n,4,sustituidas y sus derivados, composiciones que los contienen, procedimientos de preparación y aplicaciones
HRP20070498T3 (en) Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them
MY148653A (en) N, n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
HRP20080119T5 (en) Benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same
AR037098A1 (es) Proceso para preparar un compuesto intermediario derivado de halo alquil sulfona y compuestos intermediarios que se usan en dicho proceso
AR045090A1 (es) Derivados de nicotinamida utiles como inhibidores de pde4
HRP20090090T3 (en) Novel polysubstituted 1,1-pyridinylaminocyclopropanamine derivatives, processes for their preparation and pharmaceutical composition containing them
CO6311082A2 (es) Derivados de sulfonil-quinolina, procesos para su preparación y composiciones farmacéuticas que los contienen
TW200607808A (en) Pyrido-pyrimidine derivatives, preparation thereof and application thereof
HRP20080536T5 (en) Polysubstituted 1,1-pyridinyloxycyclopropanamine derivatives, process for their preparation and pharmaceutical compositions containing them
AR068372A1 (es) Derivados de n-fenilacetamida, inhibidores de la enzima soat1, y composiciones farmaceuticas y cosmeticas que los contienen
HRP20080097T5 (en) Piperazine derivatives and their use as serotonin reuptake inhibitors or as neurokinin antagonists
EA200801681A1 (ru) Новые многократно замещенные соединения пиридиниламиноалкилен- и пиридинилоксиалкиленциклопропанамина, способ их получения и фармацевтические композиции, которые их содержат